New COVID prevention shot enters first human tests
NCT ID NCT07445971
First seen Mar 04, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tests a new drug called MDX2301 to see if it can prevent COVID-19 in healthy adults and those at higher risk for severe illness. About 80 participants will receive either the drug or a placebo by injection or IV. The main goal is to check safety and how the body responds to the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
TrialMed Clinical Research Unit
RECRUITINGLas Vegas, Nevada, 89113, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
TrialMed Clinical Research Unit
RECRUITINGAustin, Texas, 78744, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.